Loading...
BELLS HEALTHCARE — Clopidogrel Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #3 buyer for Clopidogrel · $2.1M import value · 66 shipments · UNITED KINGDOM · DGFT Verified
BELLS HEALTHCARE is the #3 importer of Clopidogrel from India with $2.1M in import value and 66 verified shipments. BELLS HEALTHCARE holds a 1.3% market share in Clopidogrel imports based in UNITED KINGDOM. The company sources from 2 verified suppliers across 22 formulations shipped to 1 country. Overall, BELLS HEALTHCARE imports 4 pharmaceutical products worth $11.9M across 4 therapeutic categories.
Verified from 66 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| STERIL-GENE LIFE SCIENCES PRIVATE LIMITED | $1.8M | 60 | 87.7% |
| STERIL GENE LIFE SCIENCES PRIVATE LIMITED | $252.8K | 6 | 12.3% |
BELLS HEALTHCARE sources Clopidogrel from 2 verified Indian suppliers based on 66 customs records. The primary supplier is STERIL-GENE LIFE SCIENCES PRIVATE LIMITED accounting for 87.7% of imports.
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $4.7M | 186 | $25.3K |
| 2 | AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $4.5M | 91 | $50.0K |
| 3 | BELLS HEALTHCARE ★ | UNITED KINGDOM | $3.3M | 66 | $50.0K |
| 15 | ZENTIVA ITALIA SRL | ITALY | $3.2M | 65 | $49.2K |
| 6 | AUROLOGISTICS LLC | UNITED STATES |
BELLS HEALTHCARE ranks #3 among 1,234 Clopidogrel importers from India. Average shipment value of $50.0K compared to the market average of $42.4K. The closest competitors by value are APL SWIFT SERVICES (MALTA) LTD., and AUROLOGISTICS LLC (AUROBINDO PHARMA.
Destination countries from 66 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $2.1M | 66 | 100.0% |
BELLS HEALTHCARE imports Clopidogrel to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $2.1M.
| Formulation | Value | Shipments |
|---|---|---|
| CLOPIDOGREL 75 MG TABLETS (2X14`S) | $723.2K | 21 |
| CLOPIDOGREL 75 MG TABLETS 2X14`S | $429.4K | 10 |
| CLOPIDOGREL 75 MG TABLETS 2X14 S | $152.8K | 4 |
| CLOPIDOGREL 75 MG TABLETS (2X14`S)PCS | $105.6K | 12 |
| CLOPIDOGREL 75MG TABLETS 2X14 S | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (207600X2X14`S) | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (125300X2X14`S) | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (83700X2X14`S) | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (83220X2X14`S) | $50.0K |
What BELLS HEALTHCARE and other importers must comply with to import Clopidogrel from India
Medicines and Healthcare products Regulatory Agency (MHRA)
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
UK GMP compliance; MHRA GMP inspection of manufacturing site
India exported $52.3M worth of Clopidogrel through 6,037 shipments from 416 suppliers to 137 countries, serving 1,234 buyers globally. BELLS HEALTHCARE imports $2.1M of this total, accounting for 1.3% of India's Clopidogrel exports with 66 shipments from UNITED KINGDOM. This is verified from 66 customs shipment records covering 22 distinct formulations.
BELLS HEALTHCARE's average Clopidogrel order value is $31.2K per consignment, based on 66 shipments totaling $2.1M. BELLS HEALTHCARE is based in UNITED KINGDOM and ranks #3 among all Clopidogrel importers from India by value. The company sources from 2 verified suppliers in India.
BELLS HEALTHCARE sources Clopidogrel from 2 verified Indian suppliers: STERIL-GENE LIFE SCIENCES PRIVATE LIMITED ($1.8M, 87.7%), STERIL GENE LIFE SCIENCES PRIVATE LIMITED ($252.8K, 12.3%). This is based on 66 customs records.
BELLS HEALTHCARE ranks #3 among 1,234 Clopidogrel importers from India with a 1.3% market share. The top 3 importers are ALLOGA UK AP7 ($8.0M), NORTHSTAR DISTRIBUTION CENTER 8912 ($6.5M), APL SWIFT SERVICES MALTA LTD ($4.7M). BELLS HEALTHCARE processed 66 shipments from UNITED KINGDOM.
BELLS HEALTHCARE imports 4 products worth $11.9M. Beyond Clopidogrel, top products include Prednisolone, Paracetamol, Tamoxifen. View the complete BELLS HEALTHCARE profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Clopidogrel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for BELLS HEALTHCARE's Clopidogrel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BELLS HEALTHCARE
Full Company Profile →
4 products · $11.9M total trade · 4 categories
| $3.0M |
| 59 |
| $50.0K |
| 1 |
| CLOPIDOGREL 75 MG TABLETS (83920X2X14`S) | $50.0K | 1 |
BELLS HEALTHCARE imports 22 distinct Clopidogrel formulations from India. The top formulation is CLOPIDOGREL 75 MG TABLETS (2X14`S) with 21 shipments worth $723.2K.
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 1,234+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for BELLS HEALTHCARE.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clopidogrel. For current order-level data, contact TransData Nexus.